Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 16;23(6):3204.
doi: 10.3390/ijms23063204.

Preventing Bacterial Translocation in Patients with Leaky Gut Syndrome: Nutrition and Pharmacological Treatment Options

Affiliations
Review

Preventing Bacterial Translocation in Patients with Leaky Gut Syndrome: Nutrition and Pharmacological Treatment Options

Agata Twardowska et al. Int J Mol Sci. .

Abstract

Leaky gut syndrome is a medical condition characterized by intestinal hyperpermeability. Since the intestinal barrier is one of the essential components maintaining homeostasis along the gastrointestinal tract, loss of its integrity due to changes in bacterial composition, decreased expression levels of tight junction proteins, and increased concentration of pro-inflammatory cytokines may lead to intestinal hyperpermeability followed by the development of gastrointestinal and non-gastrointestinal diseases. Translocation of microorganisms and their toxic metabolites beyond the gastrointestinal tract is one of the fallouts of the leaky gut syndrome. The presence of intestinal bacteria in sterile tissues and distant organs may cause damage due to chronic inflammation and progression of disorders, including inflammatory bowel diseases, liver cirrhosis, and acute pancreatitis. Currently, there are no medical guidelines for the treatment or prevention of bacterial translocation in patients with the leaky gut syndrome; however, several studies suggest that dietary intervention can improve barrier function and restrict bacteria invasion. This review contains current literature data concerning the influence of diet, dietary supplements, probiotics, and drugs on intestinal permeability and bacterial translocation.

Keywords: bacterial translocation; leaky gut syndrome; nutrients; probiotics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Consequences of bacterial translocation.
Figure 2
Figure 2
Factors influencing bacterial translocation (made with the use of free materials from www.canva.com accessed on 15 October 2021).

Similar articles

Cited by

References

    1. Sperber A.D., Bangdiwala S.I., Drossman D.A., Ghoshal U.C., Simren M., Tack J., Whitehead W.E., Dumitrascu D.L., Fang X., Fukudo S., et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160:99–114.e3. doi: 10.1053/j.gastro.2020.04.014. - DOI - PubMed
    1. Odenwald M.A., Turner J.R. Intestinal Permeability Defects: Is It Time to Treat? Clin. Gastroenterol. Hepatol. 2013;11:1075–1083. doi: 10.1016/j.cgh.2013.07.001. - DOI - PMC - PubMed
    1. Kato T., Honda Y., Kurita Y., Iwasaki A., Sato T., Kessoku T., Uchiyama S., Ogawa Y., Ohkubo H., Higurashi T., et al. Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers. PLoS ONE. 2017;12:e0175626. doi: 10.1371/journal.pone.0175626. - DOI - PMC - PubMed
    1. Borisova M.A., Achasova K.M., Morozova K.N., Andreyeva E.N., Litvinova E.A., Ogienko A.A., Morozova M.V., Berkaeva M.B., Kiseleva E., Kozhevnikova E.N. Mucin-2 knockout is a model of intercellular junction defects, mitochondrial damage and ATP depletion in the intestinal epithelium. Sci. Rep. 2020;10:21135. doi: 10.1038/s41598-020-78141-4. - DOI - PMC - PubMed
    1. Gecse K., Róka R., Séra T., Rosztóczy A., Annahazi A., Izbéki F., Nagy F., Molnár T., Szepes Z., Pávics L., et al. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis. Digestion. 2012;85:40–46. doi: 10.1159/000333083. - DOI - PubMed